Skip to content
Loading Events

« All Events

Review period expiry for use of 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)

4th January 2033

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)

  • 1 use applied for by Eli Lilly Kinsale Limited

Reference of the decision

Date of decision

Substance name

Holder of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

C(2022) 1497

16 March 2022

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated

(4-tert-OPnEO)

EC No: -, CAS No:-

Eli Lilly Kinsale Limited, Dunderrow, Kinsale, P17 NY71 Cork, Co. Cork Ireland

REACH/22/6/0

Industrial use as a patient safety viral inactivation reagent in the manufacture of human medicines produced from biological systems

4 January 2033

Details

Date:
4th January 2033
Event Category:
Event Tags:

Organiser

European Commission
View Organiser Website